At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+high T-Cell Fraction

被引:56
作者
Glisic-Milosavljevic, Sanja [1 ,2 ,3 ]
Waukau, Jill [1 ,2 ,3 ]
Jailwala, Parthav [1 ,2 ,3 ]
Jana, Srikanta [1 ,2 ,3 ]
Khoo, Huoy-Jii [1 ,2 ,3 ]
Albertz, Hope [4 ]
Woodliff, Jeffrey [5 ]
Koppen, Marilyn [1 ,2 ,3 ]
Alemzadeh, Ramin [6 ]
Hagopian, William [7 ]
Ghosh, Soumitra [1 ,2 ,3 ]
机构
[1] Med Coll Wisconsin, Max McGee Natl Ctr Juvenile Diabet, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Human Mol Genet Ctr, Milwaukee, WI 53226 USA
[3] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA
[4] Med Coll Wisconsin, Blood Ctr Wisconsin, Milwaukee, WI 53226 USA
[5] Med Coll Wisconsin, Dept Pediat, Flow Cytometry Core Facil, Milwaukee, WI 53226 USA
[6] Childrens Hosp Wisconsin, Med Coll Wisconsin, Diabet Ctr Pediat Endocrinol & Metab, Milwaukee, WI 53201 USA
[7] Pacific NW Res Inst, Seattle, WA USA
来源
PLOS ONE | 2007年 / 2卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0000146
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. In experimental models, Type 1 diabetes (T1D) can be prevented by adoptive transfer of CD4+CD25+ (FoxP3+) suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. Methods and Findings. T-cell apoptosis was evaluated in children and adolescent (35 females/40 males) subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25- T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects (p<0.0001 for both groups). Subjects at high risk for developing T1D ( 2-3Ab+ve) show a similar trend (p<0.02 and p<0.01, respectively). On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects (p = NS). Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage (15.3 +/- 2.2) compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects (6.1 +/- 1.7) (p<0.002). Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells (p = 0.0007 and p = 0.007, respectively). Conclusions. There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects.
引用
收藏
页数:7
相关论文
共 35 条
  • [1] The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
    Allan, SE
    Passerini, L
    Bacchetta, R
    Crellin, N
    Dai, MY
    Orban, PC
    Ziegler, SF
    Roncarolo, MG
    Levings, MK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) : 3276 - 3284
  • [2] Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells
    Baecher-Allan, C
    Wolf, E
    Hafler, DA
    [J]. CLINICAL IMMUNOLOGY, 2005, 115 (01) : 10 - 18
  • [3] Inhibition of human CD4+CD25+high regulatory T cell function
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6210 - 6217
  • [4] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    Bennett, CL
    Christie, J
    Ramsdell, F
    Brunkow, ME
    Ferguson, PJ
    Whitesell, L
    Kelly, TE
    Saulsbury, FT
    Chance, PF
    Ochs, HD
    [J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
  • [5] Functional defects and the influence of age on the frequency of CD4+CD25+ T-Cells in type 1 diabetes
    Brusko, TM
    Wasserfall, CH
    Clare-Salzler, MJ
    Schatz, DA
    Atkinson, MA
    [J]. DIABETES, 2005, 54 (05) : 1407 - 1414
  • [6] Regulating the immune system: the induction of regulatory T cells in the periphery
    Buckner, JH
    Ziegler, SF
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (05) : 215 - 222
  • [7] Dosch HM, 1999, J IMMUNOL, V163, P6933
  • [8] EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
  • [9] T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
    Fahlén, L
    Read, S
    Gorelik, L
    Hurst, SD
    Coffman, RL
    Flavell, RA
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) : 737 - 746
  • [10] High glucose causes apoptosis in cultured human pancreatic Islets of Langerhans - A potential role for regulation of specific Bcl family genes toward an apoptotic cell death program
    Federici, M
    Hribal, M
    Perego, L
    Ranalli, M
    Caradonna, Z
    Perego, C
    Usellini, L
    Nano, R
    Bonini, P
    Bertuzzi, F
    Marlier, LNJL
    Davalli, AM
    Carandente, O
    Pontiroli, AE
    Melino, G
    Marchetti, P
    Lauro, R
    Sesti, G
    Folli, F
    [J]. DIABETES, 2001, 50 (06) : 1290 - 1301